Press Releases
May. 1, 2026
MULTIMEDIA UPDATE - KEITI to Showcase South Korean Advanced Green Solutions at IFAT Munich 2026
Indeterminate
GlobeNewswire, Inc.
4 hours ago
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
Indeterminate
GlobeNewswire, Inc.
Apr. 30, 2026
KEITI to Showcase South Korean Advanced Green Solutions at IFAT Munich 2026
Indeterminate
GlobeNewswire, Inc.
9 hours ago
Industrial 5G Network Slicing for Robotics Market to Reach $8.75 Billion by 2030 with 31.7% CAGR
Neutral
EIN Presswire
Apr. 30, 2026
First exhibitors of WMF 2026: global innovation in AI, tech and international ecosystems
Neutral
EIN Presswire
Apr. 30, 2026
Gene Editing Market Size to Reach US$30.5 Bn by 2033 at 15.6% CAGR | Persistence Market Research
Neutral
EIN Presswire
Apr. 30, 2026
Driving the Global Food Revolution: Japan’s Cutting-Edge Food Processing Technology Takes Center Stage
Neutral
EIN Presswire
Apr. 29, 2026
Perfusion Radiology Market to Reach USD 7.89 Billion by 2032 at 8.4% CAGR, Maximize Market Research
Neutral
EIN Presswire
Apr. 28, 2026
Decanter Centrifuge Market to Surpass USD 2.77 Billion by 2032, Analysis by Maximize Market Research
Neutral
EIN Presswire
Apr. 21, 2026
India, South Korea Seal Several MoUs in Different Fields
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Apr. 28, 2026
Preclinical Imaging Market Size to Reach USD 13.49 Billion by 2032, Reports Maximize Market Research
Neutral
EIN Presswire
Apr. 21, 2026
US Restricts Intelligence Sharing with South Korea over Nuclear Leak Row
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Apr. 28, 2026
3D Digital Asset Market: Every Object Now Exists Twice, USD 72.07 Billion by 2032, Maximize Market Research
Neutral
EIN Presswire
Apr. 28, 2026
Homeopathic Medicine Market to Surpass USD 20.45 Billion by 2032 at 13.8% CAGR | Maximize Market Research
Neutral
EIN Presswire
Apr. 27, 2026
China, India, and Iran Among the Fastest-Rising Scientific Nations According to 2025 ScholarGPS Rankings
Neutral
EIN Presswire
Apr. 21, 2026
ZenaTech Continues International Expansion Opening New Offices in South Korea and the United Kingdom
Indeterminate
GlobeNewswire, Inc.
Apr. 21, 2026
Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia
Indeterminate
GlobeNewswire, Inc.